247 related articles for article (PubMed ID: 22673947)
1. [Neurotoxicity due to methotrexate in paediatric patients. Description of the clinical symptoms and neuroimaging findings].
Garcia-Puig M; Fons-Estupina MC; Rives-Sola S; Berrueco-Moreno R; Cruz-Martinez O; Campistol J
Rev Neurol; 2012 Jun; 54(12):712-8. PubMed ID: 22673947
[TBL] [Abstract][Full Text] [Related]
2. Methotrexate-induced subacute neurotoxicity in a child with acute lymphoblastic leukemia carrying genetic polymorphisms related to folate homeostasis.
Vagace JM; Caceres-Marzal C; Jimenez M; Casado MS; de Murillo SG; Gervasini G
Am J Hematol; 2011 Jan; 86(1):98-101. PubMed ID: 21064136
[TBL] [Abstract][Full Text] [Related]
3. Methotrexate-related neurotoxicity in the treatment of childhood acute lymphoblastic leukemia.
Shuper A; Stark B; Kornreich L; Cohen IJ; Avrahami G; Yaniv I
Isr Med Assoc J; 2002 Nov; 4(11):1050-3. PubMed ID: 12489505
[TBL] [Abstract][Full Text] [Related]
4. Methotrexate-associated alterations of the folate and methyl-transfer pathway in the CSF of ALL patients with and without symptoms of neurotoxicity.
Vezmar S; Schüsseler P; Becker A; Bode U; Jaehde U
Pediatr Blood Cancer; 2009 Jan; 52(1):26-32. PubMed ID: 19006245
[TBL] [Abstract][Full Text] [Related]
5. Methotrexate-induced neurotoxicity and leukoencephalopathy in childhood acute lymphoblastic leukemia.
Bhojwani D; Sabin ND; Pei D; Yang JJ; Khan RB; Panetta JC; Krull KR; Inaba H; Rubnitz JE; Metzger ML; Howard SC; Ribeiro RC; Cheng C; Reddick WE; Jeha S; Sandlund JT; Evans WE; Pui CH; Relling MV
J Clin Oncol; 2014 Mar; 32(9):949-59. PubMed ID: 24550419
[TBL] [Abstract][Full Text] [Related]
6. A rare complication of intrathecal methotrexate in a child with acute lymphoblastic leukemia.
Tufekci O; Yilmaz S; Karapinar TH; Gozmen S; Cakmakci H; Hiz S; Irken G; Oren H
Pediatr Hematol Oncol; 2011 Sep; 28(6):517-22. PubMed ID: 21699468
[TBL] [Abstract][Full Text] [Related]
7. Age and high-dose methotrexate are associated to clinical acute encephalopathy in FRALLE 93 trial for acute lymphoblastic leukemia in children.
Dufourg MN; Landman-Parker J; Auclerc MF; Schmitt C; Perel Y; Michel G; Levy P; Couillault G; Gandemer V; Tabone MD; Demeocq F; Vannier JP; Leblanc T; Leverger G; Baruchel A
Leukemia; 2007 Feb; 21(2):238-47. PubMed ID: 17170721
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of methotrexate-induced stroke-like neurotoxicity.
Watanabe K; Arakawa Y; Oguma E; Uehara T; Yanagi M; Oyama C; Ikeda Y; Sasaki K; Isobe K; Mori M; Hanada R; Koh K
Int J Hematol; 2018 Dec; 108(6):630-636. PubMed ID: 30182170
[TBL] [Abstract][Full Text] [Related]
9. Comparison of long-term neurocognitive outcomes in young children with acute lymphoblastic leukemia treated with cranial radiation or high-dose or very high-dose intravenous methotrexate.
Spiegler BJ; Kennedy K; Maze R; Greenberg ML; Weitzman S; Hitzler JK; Nathan PC
J Clin Oncol; 2006 Aug; 24(24):3858-64. PubMed ID: 16921038
[TBL] [Abstract][Full Text] [Related]
10. Long-term cognitive outcome, brain computed tomography scan, and magnetic resonance imaging in children cured for acute lymphoblastic leukemia.
Iuvone L; Mariotti P; Colosimo C; Guzzetta F; Ruggiero A; Riccardi R
Cancer; 2002 Dec; 95(12):2562-70. PubMed ID: 12467071
[TBL] [Abstract][Full Text] [Related]
11. Transient encephalopathy after intrathekal methotrexate chemotherapy: diffusion-weighted MRI.
Küker W; Bader P; Herrlinger U; Heckl S; Nägele T
J Neurooncol; 2005 May; 73(1):47-9. PubMed ID: 15933817
[TBL] [Abstract][Full Text] [Related]
12. Dextromethorphan Administration on Day 0 and Day 7 for Secondary Prevention of Methotrexate-induced Neurotoxicity in Childhood Acute Lymphoblastic Leukemia: A Retrospective Case Series.
Fustino NJ; Juhl K; Leister J
J Pediatr Hematol Oncol; 2021 Mar; 43(2):e284-e287. PubMed ID: 31929386
[TBL] [Abstract][Full Text] [Related]
13. Clinical and radiological characteristics of methotrexate-induced acute encephalopathy in pediatric patients with cancer.
Inaba H; Khan RB; Laningham FH; Crews KR; Pui CH; Daw NC
Ann Oncol; 2008 Jan; 19(1):178-84. PubMed ID: 17947226
[TBL] [Abstract][Full Text] [Related]
14. Acute and long-term neurologic complications in children with acute lymphoblastic leukemia.
Aytaç S; Yetgin S; Tavil B
Turk J Pediatr; 2006; 48(1):1-7. PubMed ID: 16562778
[TBL] [Abstract][Full Text] [Related]
15. A woman who couldn't speak: report of methotrexate neurotoxicity.
Szawarski P; Chapman CS
Postgrad Med J; 2005 Mar; 81(953):194-5. PubMed ID: 15749798
[TBL] [Abstract][Full Text] [Related]
16. Prevention of CNS recurrence in childhood ALL: results with reduced radiotherapy combined with CNS-directed chemotherapy in four consecutive ALL-BFM trials.
Schrappe M; Reiter A; Henze G; Niemeyer C; Bode U; Kühl J; Gadner H; Havers W; Plüss H; Kornhuber B; Zintl F; Ritter J; Urban C; Niethammer D; Riehm H
Klin Padiatr; 1998; 210(4):192-9. PubMed ID: 9743952
[TBL] [Abstract][Full Text] [Related]
17. [Neurotoxicity during induction treatment of childhood acute lymphoblastic leukaemia--two case reports].
Kostić G; Jovancić D; Saranac L; Bjelaković B
Srp Arh Celok Lek; 2009; 137(5-6):266-70. PubMed ID: 19594068
[TBL] [Abstract][Full Text] [Related]
18. Diffusion and perfusion imaging in subacute neurotoxicity following high-dose intravenous methotrexate.
Eichler AF; Batchelor TT; Henson JW
Neuro Oncol; 2007 Jul; 9(3):373-7. PubMed ID: 17522329
[TBL] [Abstract][Full Text] [Related]
19. Reversible acute methotrexate leukoencephalopathy: atypical brain MR imaging features.
Ziereisen F; Dan B; Azzi N; Ferster A; Damry N; Christophe C
Pediatr Radiol; 2006 Mar; 36(3):205-12. PubMed ID: 16369780
[TBL] [Abstract][Full Text] [Related]
20. Dextromethorphan is effective in the treatment of subacute methotrexate neurotoxicity.
Drachtman RA; Cole PD; Golden CB; James SJ; Melnyk S; Aisner J; Kamen BA
Pediatr Hematol Oncol; 2002; 19(5):319-27. PubMed ID: 12078863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
